Winchester, MA, United States of America

Mark Evan Lindsay

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Evan Lindsay. Retrieved from https://idiyas.com/inventor/mark-evan-lindsay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Evan Lindsay and His Work in Gene Therapy

Introduction

Mark Evan Lindsay is an inventor associated with Winchester, Massachusetts, and The Brigham and Women’s Hospital, Inc. His patent work includes an invention focused on ENPP1 gene therapy for vascular disease.

Latest Patents

Lindsay is listed as an inventor on 1 patent: “ENPP1 Gene Therapy for the Treatment of Vascular Disease.” The patent concerns a gene-therapy approach directed at vascular disease.

Career Highlights

Lindsay’s listed patent reflects work connected with biomedical research and potential therapeutic applications. The available information identifies The Brigham and Women’s Hospital, Inc. as his affiliated organization.

Collaborations

His listed collaborators include Natalie Artzi and Christian Lacks Lino Cardenas.

Conclusion

Mark Evan Lindsay’s patent activity highlights his contribution to research exploring ENPP1 gene therapy as a potential approach to treating vascular disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…